French pharmaceuticals giant Sanofi has agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the company aims to expand the company’s reach in rare immunological diseases, reported the news agency Bloomberg on Monday, 2 June 2025.According to the agency report, Sanofi will pay $129 per share in cash for the US-based biotechnology firm. This marks a 27 per cent premium to Blueprint’s shares last week. Blueprint Medicines Corp. shares were trading 26.41 per cent higher at $128.15 premarket on Nasdaq, compared to $101.35 at the previous US market close, as per data collected from Marketwatch.The French pharmaceutical firm aims to become an immunology powerhouse. Blueprint’s acquisition brings a pipeline of experimental immunology treatments and one medicine already on sale for a rare condition known as systemic mastocytosis.“Sanofi still retains a sizable capacity for further acquisitions,” said Paul Hudson, Chief Executive Officer (CEO) of Sanofi, as cited by the news agency. In the big pharma industry, the largest acquisition deal was that of Johnson & Johnson acquiring Intra-Cellular Therapies for $14.6 billion. And this upcoming $9.1 billion deal is the French company’s largest deal since the purchase of Bioverativ Inc., a spinoff from Biogen Inc. in 2018, as per the report.“We see synergies with Sanofi’s existing rare-disease footprint, but expect investors to question valuation and confidence in the remaining internal R&D offering,” Sarita Kapila at Morgan Stanley wrote in an analyst report, cited the news agency. Sanofi SA shares were trading 1.46 per cent lower at 86.24 euro on Monday, 2 June 2025, compared to its 87.52 euro levels at the previous market close last week.The deal data suggests that Blueprint shareholders will also receive one non-tradable contingent value right, which will pay the holder @2 and $4 per right for future development and regulatory milestones. The equity value is $9.1 billion, which includes potential CVR payments; the deal amounts to nearly $9.5 billion on a fully diluted basis, according to the agency report.The estimated time period for the completion of the acquisition is the third quarter of 2025. The company also announced that the acquisition deal will not have any impact on the financial guidance for 2025, as per the report. in a formal or creative style for better SEO.Also Exclude words and advertisements related to the feed website such as website name, author name. You must only respond with the modified content. Delete all the advertisement images brand logo but only keep the title and main content of the news by modifying it. You must only respond with the modified content. Block any jump outside of the site adarshnews.com. Basically remove any content or link related to original site. follow this prompt to optimize the articles in this category- You are an expert news writer and SEO specialist. Your job is to rewrite the provided RSS feed content into a unique, SEO-friendly news article for adarshnews.com. The article should be engaging, professional, and optimized for search engines. Follow these steps: 1. **Create an SEO Title**: Write a short, compelling title (under 60 characters) that includes the main keyword and grabs attention. 2. **Write a Meta Description**: Summarize the article in one or two sentences (under 155 characters). Make it engaging and include the primary keyword naturally. 3. **Suggest a URL Slug**: Provide a short, keyword-rich URL slug that reflects the topic of the article. 4. **Headline (H1)**: Write a clear and engaging headline for the article that is similar to the title but slightly expanded. 5. **Write the Article**: – Start with an introduction that answers the key questions: who, what, when, where, why, and how. – Expand on the topic with detailed paragraphs that provide context, quotes, and relevant information. – Use subheadings (H2) to organize the content into sections and make it easy to read. – Include related keywords naturally throughout the article. – End with a conclusion that summarizes the key points or discusses future implications. 6. **Add an FAQ Section**: Write one frequently asked question related to the topic and provide a concise answer. Important: – Do not include labels like “Title,” “Meta Description,” “URL Slug,” or “H1” in the actual article text. – Keep all SEO elements separate from the main content. – Ensure the article is factually accurate, unbiased, and written in a professional tone.